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ABSTRACT
Objectives The objective of this randomised controlled
trial in Kenya was to assess the effect of delivering
sexual and reproductive health (SRH) information via
text message to young people on their ability to reject
contraception-related myths and misconceptions.
Design and setting A three-arm, unblinded randomised
controlled trial with a ratio of 1:1:1 in Kwale County, Kenya.
Participants and interventions A total of 740 youth
aged 18–24 years were randomised. Intervention arm
participants could access informational SRH text messages
on-demand. Contact arm participants received once
weekly texts instructing them to study on an SRH topic on
their own. Control arm participants received standard care.
The intervention period was 7 weeks.
Primary outcome We assessed change myths believed at
baseline and endline using an index of 10 contraception-
related myths. We assessed change across arms using
difference of difference analysis.
Results Across arms, <5% of participants did not have
any formal education, <10% were living alone, about 50%
were single and >80% had never given birth. Between
baseline and endline, there was a statistically significant
drop in the average absolute number of myths and
misconceptions believed by intervention arm (11.1%,
95% CI 17.1% to 5.2%), contact arm (14.4%, 95% CI
20.5% to 8.4%) and control arm (11.3%, 95% CI 17.4% to
5.2%) participants. However, we observed no statistically
significant difference in the magnitude of change across
arms.
Conclusions We are unable to conclusively state that the
text message intervention was better than text message
‘contact’ or no intervention at all. Digital health likely has
potential for improving SRH-related outcomes when used
as part of multifaceted interventions. Additional studies
with physical and geographical separation of different
arms is warranted.
Trial registration number ISRCTN85156148.

INTRODUCTION
There is a high unmet need for sexual and
reproductive health (SRH) information and
services, for both married and unmarried
youth worldwide. Data from 61 low-income

Strengths and limitations of this study
► This study included two digital intervention arms,

meaning that it would be possible to determine
whether changes in outcomes were due to sexual
and reproductive health (SRH) content delivered by
phone, or participants being ‘nudged’ by phone to
think about (and learn about) their SRH.
► The study intentionally did not power sample size
around SRH behavioural outcomes, building on previous research that light-touch digital interventions
alone may not be enough to see behavioural change
in such a complex area of health—instead the primary outcome focuses on SRH knowledge.
► A key limitation is that the study’s individual-level
randomisation of young people living near each
other is likely to have resulted in contamination between arms.

and middle-income countries show that 33
million women aged 15–24 have an unmet
need for contraception.1 In Kenya, the 2014
Demographic and Health Survey found that
modern contraceptive use among all adolescents age 15–19 years is low (9.3%) compared
with all women aged 15–49 years (39.1%).2
Partly as a result, the number of adolescents
aged 15–19 years who were pregnant or
mothers has stagnated at 18% between 2008
and 2014.2 3
Sexually active young people face a variety
of obstacles to access and use modern contraceptives. They may encounter financial,
cultural, social, legal barriers, fear of side
effects (eg, infertility and adverse reactions)
or cultural norms that restrict their access
to contraception services in health facilities.4–7 Additionally, contraception myths and
misconceptions can negatively affect access
to and use of SRH services.8 9 Misinformation
and myths/misconceptions are often learnt
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Participants and setting
The study was conducted in Kwale County, one of the
six counties in the Coastal region of Kenya. The study
area consisted of select enumeration areas (EAs) in six
Kwale County sublocations which border each other:
Ngombeni, Kitivo, Simkumbe, Mkoyo, Gombato and
Ukunda. Eligibility criteria was as follows: youth (male
and female) aged 18–24; literate; had their own mobile
phone at the time of recruitment and reported regular
use; reported current use of text messaging.
The Kenya National Bureau of Statistics provided
a list of EAs for the six sub-locations. From this list, we
randomly selected 21 EAs to be mapped. During the
mapping (October 2017), data collectors visited all households and enumerated anyone in the home who was
age-eligible to participate. Then, we randomly selected
one eligible participant from each household. Starting
in February 2018, trained data collectors returned to
households and attempted to recruit the selected youth.
After consenting to participate, participants completed a
baseline survey. Both baseline and endline surveys were
implemented by trained data collectors, who entered
participants’ responses into a webform on a tablet. For
a few sensitive questions relating to previous contraception use and sexual behaviour, participants entered their
responses onto the tablet themselves. Participants were
then remotely randomised into one of three arms. Intervention and contact arm participants received their first
message the following day.

METHODS
Study design
This was a three-arm RCT (1:1:1 allocation) involving
youth age 18–24 years. The trial ran for 7 weeks, with
assessments at baseline and endline. The study methods
have been described elsewhere in full,29 but are described
briefly below.

Interventions
The interventions were categorised as per WHO classification of digital health interventions.30 Arm 1 (intervention
arm) was an on-demand information service to clients
(WHO Classification 1.6). Participants received access
to one domain of ARMADILLO content (eg, ‘puberty
and anatomy’ or ‘pregnancy prevention’) each week and
could request any ‘subdomain’ that interested them from
the menu (eg, ‘menstruation’ or ‘physical changes’ for
the puberty and anatomy domain or ‘implants’ or ‘male
condoms’ for the pregnancy prevention domain) for free
for the entire week (see online supplemental figure 1).
Arm 2, (contact arm) employed targeted client communication (WHO Classification 1.1). Participants received
the same system-initiated contacts as arm 1 participants
but without access to the ARMADILLO content itself.
Instead, a once-
weekly SMS alerted them to an SRH
domain for that week (eg, relationships, pregnancy, HIV)
and encouraged them to learn on their own (see online
supplemental figure 2). At the end of the week, participants in both arms were provided with a single SMS-based
quiz question on that domain’s content. If the participant answered (correctly or not), they received a small
amount of airtime (1USD). Intervention and contact
messages were available in either Swahili or English, per
the participant’s preference. All SMS costs were reverse-
billed to the study, so intervention and contact arm participants incurred no costs from their participation. Those
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from social networks.10 11 In this paper, we describe myths
and misconceptions as those being communal or widespread beliefs about effects of contraceptives, which are
distinct from individuals’ experiences with contraception-
related side effects.12
The proliferation of mobile phone technology, and its
popularity and ownership with young people in particular,13 14 provides an innovative way to educate young
people on contraception and their health more broadly.
There are indications that health promotion campaigns
among adolescents and young people through text
messaging may contribute to improved SRH knowledge, behaviours and outcomes.15 However, there is less
rigorous research and documentation of SRH mobile
phone interventions for adolescents and young people
in developing countries.16 In Kenya in particular, an estimated 93% of households already owned a mobile phone
by 2011.17
Mobile phone-based digital health interventions have
been successfully used in HIV programmes,18 19 postabortion care20 and to address chronic disease conditions.21
Providing broader SRH content, including contraception
information, via mobile phones to young people would
appear to be a natural strategy to reach them,22 increase
their contraception knowledge23 and improve correct
contraception use.24 After all, when it comes to ‘sensitive’
SRH content, mobile phones can privately deliver information without stigma or judgement. However, the evidence
that digital health interventions can improve youth SRH-
related outcomes, including contraception knowledge
and uptake, is yet to be significantly established.25–27
To address this gap, the WHO’s Department of Sexual
and Reproductive Health and Research partnered with
research partners in Peru and Kenya to develop the
Adolescent/Youth Reproductive Mobile Access and
Delivery Initiative for Love and Life Outcomes (ARMADILLO) Study. The ARMADILLO intervention used
short message service (SMS, also known as ‘text message’)
to deliver SRH information on-demand via a numbers-
based menu. The content was developed in the study’s
formative stage around several SRH ‘domains’ of interest
to policy-
makers and young people alike.28 The intervention was evaluated using a three-
arm randomised
controlled trial (RCT). This paper reports on the Kenya
study’s primary outcome: are young people with access
to the ARMADILLO intervention better able to reject
contraception myths and misconceptions as compared
with periodic SMS encouraging self-
learning or usual
care (no intervention).

Open access
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Myths and misconceptions

► Health—People who use contraceptives end up with health

problems.
► Body shape—Hormonal contraceptives are fattening.
► Infertility—(1) After a woman uses contraceptive methods, it is dif-

►
►
►
►
►

ficult to get pregnant, and (2) use of a contraceptive injection can
make a woman permanently infertile.
Harm—Contraceptives can harm a woman’s womb.
Sex drive—Contraceptives reduce women’s sexual urges.
Cancer—Contraceptives can cause cancer.
Malformations—Contraceptives can give you deformed babies.
Social constructs—(1) Birth control should be a female concern
and (2) women who use family planning/birth-spacing may become
promiscuous.

randomised to arm 3 (control arm) received standard of
care (no messages).
Assessments and outcome
The primary outcome was assessed using an index developed by the research team of 10 contraception myths and
misconceptions (box 1). These were identified based on
literature review and a series of focus group discussions
with young people prior to the start of the RCT. In these
sessions, young people used individual activities and
group discussion centred around short vignettes of young
couples thinking about starting contraception to describe
local concerns around contraception use.31 At baseline
and endline, RCT participants were asked to state how
much they agreed or disagreed with a given statement
based on a four-point Likert scale.
Sample size
The sample size was calculated such that it provided 80%
power to detect a 10% change in mean number of myths
believed from baseline to endline, assuming that baseline
level of belief was 55%, type 1 error at 5% using two-sided
Z test with continuity correction and unpooled variance
and accounting for a dropout rate of up to 20%. The
sample size accounted for Bonferroni correction due to
three-arm pairwise comparisons. Based on the aforementioned, a minimum number of participants to be sampled
was 705, split evenly across intervention, contact and
control arms (1:1:1).
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Randomisation procedures
Participants were individually randomised to either intervention, contact or control group using a ratio of 1:1:1 as
per computer-generated randomisation schedule developed using N
 ode.js and docker. All the study participants
had equal probability of being assigned to either arm.
Allocation took place after the participant had completed
the baseline survey. ARMADILLO was an open-
label
trial; however, neither the technological partner nor the
research team had any control of arm assignments.

Data analysis
The 10 items of the primary outcome were dichotomised
from the original Likert scale (strongly agree, agree,
disagree and strongly disagree) as follows: (1) agree and
strongly agree (participant believed the myth—bad)
were recoded as agree and coded as 1; (2) disagree and
strongly disagree (participant rejected the myth—good)
were recoded as disagree and coded as 0. A participant
score for the 10 questions was generated with a total
maximum score of 10, corresponding to the number of
myths/misconceptions that the participant believed. The
average number of myths/misconceptions believed by
participants in each arm was computed. There were no
missing values for the 10 items across all arms. The study
participants responded to all the 10 primary outcome
questions in the assessment.
The baseline factors were described using proportions.
To ensure that oversampling in certain arms had no effect
on the randomisation, we performed χ2 tests on demographic characteristics to confirm that there were no
baseline differences between arms. To assess attrition bias
(a systematic error caused by unequal loss of participants
from the trial between the baseline and the endline),
we used Fisher’s exact χ2 tests for the sociodemographic
variables to test whether participants lost to follow-up
differed across the trial arms (online supplemental table
1) as well as if they differed from those who responded as
a function of study group (online supplemental table 2).
First, we present proportions of those who believed in
the myths at baseline and endline for all arms and the
percentage change in the myths believed between the
two periods. To obtain the average number of myths
believed per participant, we computed (using the sum of
the dichotomised 10-item response) the number of myths
believed for each participant at baseline and at endline.
Then for each participant, we computed the average
number of myths believed (expressed as a percentage) at
the baseline and at endline (by dividing the sum of myths
believed by 10 and multiplying by 100). Next, for each
participant, his or her absolute change in the average
myths believed between the endline and baseline was
computed (endline minus baseline).
Normality of the absolute changes in the myths believed
was tested using the quantile-quantile plots. As the distribution of the absolute changes in the myths believed was
normally distributed, analysis of variance (ANOVA) test
of equality of group means was used to test the between
group differences in the means of the absolute myths
change. We estimated the difference-in-differences (DID)
of the average number of myths believed by participants
in a given arm to evaluate the effect of the ARMADILLO
intervention to dispel myths and misconceptions about
contraception. DID tells us whether the expected mean
change in the number of myths and misconceptions
believed from baseline to endline was different in the
groups compared. DID is calculated by subtracting the
average of the outcome in the control or contact arm
from the average of the outcome in the intervention arm

Box 1

Open access

Figure 1 ARMADILLO Kenya’s Consolidated Standards of Reporting Trials diagram. ARMADILLO, Adolescent/Youth
Reproductive Mobile Access and Delivery Initiative for Love and Life Outcomes; CC, complete case; PP, per protocol.
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and all were conducted in accordance with a prespecified
(d1), where the outcome is the change in percentage
statistical analysis plan.
number of myths believed by each individual between the
endline and baseline. DID was also used to assess changes
Patients and public involvement statement
in the average proportion of myths believed per participant between
the
and the contact
{[
( (control ))
( ( arm (d))]
} ARMADILLO’s population of ‘young people’ were
2).
Mean Yi Endline − Mean Yi Baseline Intervention involved in the study from its initial, formative stage,28 32
d̂1 =
{[
( (
))
( (
))] }
which included message content development. They and
Mean Yi Endline − Mean Yi Baseline j
the broader community continued engagement through


{[
( (
( (
))
))]
} this trial through the ARMADILLO community adviMean Yi Endline − Mean Yi Baseline Contact − sory board (CAB) consisting of representatives from
d̂2 =
( (
))
( (
))]
}
{[
the Ministries of Health, Education and Social Services;
Mean Yi Endline − Mean Yi Baseline Control
 youth-led organisations; area chiefs; healthcare workers


providing SRH services to adolescents; and young people
themselves. CAB members provided technical and field
Where i refer to the ith individual in the trial arm; while
support throughout the data collection period. Additionj=contact or control
ally, young people identified from the study area were
All analyses were based on complete-case (CC) dataset
trained as data collectors and hired to enumerate young
while analyses based on per-protocol (PP) dataset were
people in the area as well as recruit and implement baseused for sensitivity analysis. Participants were included in
line and endline surveys with study participants. Young
the analysis provided that they had completed both basedata collectors’ input also shaped recruitment hours and
line and endline surveys. In this case, the ITT analysis was
strategies. A dissemination involving local and national
equivalent to the CC.
stakeholders took place in July 2019—selected young
Participants were included in the PP analysis provided
data collectors participated in the dissemination meeting
that they had completed baseline and endline surveys,
and shared their feedback.
and that the intervention system could confirm that they
had (1) received the ARMADILLO message domain associated with the primary outcome (pregnancy prevention);
RESULTS
and (2) requested at least one message from this domain.
A total of 740 men and women aged 18–24 years were
Results with a type I error of p<0.05 in two-sided tests were
randomised into intervention, contact and control arms
considered statistically significant. Where Bonferroni
(figure 1).
correction was applied for the pairwise comparisons of
In the intervention period which lasted 7 weeks, 116
the three study arms, p<0.017 were considered statistically
of the 740 (16%) study participants dropped out over
significant. Analyses were performed using Stata V.15,

Open access

Characteristic
Age of the participant
 18–19 years

Intervention (I)

Contact (P)

Control (C)

Total

N=255,
n (%)

N=249,
n (%)

N=236,
n (%)

N=740,
n (%)

62 (24.3)

55 (22.09)

53 (22.5)

170 (23.0)

193 (75.7)

194 (77.91)

183 (77.5)

570 (77.0)

 Male

134 (52.6)

133 (53.41)

126 (53.4)

393 (53.1)

 Female

121 (47.5)

116 (46.59)

110 (46.6)

347 (46.9)

 20–24 years
Sex

Education level
 Never gone to school
 Primary school
 Secondary school
 Postsecondary education

9 (3.5)

7 (2.81)

12 (5.1)

28 (3.8)

92 (36.1)

97 (38.96)

80 (33.9)

269 (36.4)

117 (45.9)

118 (47.39)

119 (50.4)

354 (47.8)

37 (14.5)

27 (10.84)

25 (10.6)

89 (12.1)

34 (13.3)

38 (15.26)

43 (18.2)

115 (15.5)

9 (3.5)

9 (3.61)

9 (3.8)

27 (3.7)

20 (7.8)

17 (6.83)

21 (8.9)

58 (7.8)

Sublocation
 Ngombeni
 Kitivo
 Simkumbe
 Mkoyo

8 (3.1)

8 (3.21)

8 (3.4)

24 (3.2)

17 (6.7)

11 (4.42)

9 (3.8)

37 (5.0)

167 (65.5)

166 (66.67)

146 (61.9)

479 (64.7)

24 (9.4)

21 (8.43)

21 (8.9)

66 (8.9)

231 (90.6)

228 (91.57)

215 (91.1)

674 (91.1)

 Single

128 (50.2)

121 (48.59)

118 (50.0)

367 (49.6)

 Friends with benefits/dating/cohabiting/engaged

109 (42.8)

104 (41.77)

92 (39.0)

305 (41.2)

18 (7.1)

24 (9.64)

26 (11.0)

68 (9.2)

224 (87.8)

211 (84.7)

191 (80.9)

626 (84.6)

24 (9.4)

28 (11.2)

35 (14.8)

87 (11.8)

7 (2.8)

10 (4.0)

10 (4.2)

27 (3.7)

224 (87.8)

211 (84.7)

191 (80.9)

626 (84.6)

18 (7.1)
13 (5.1)

22 (8.8)
16 (6.4)

23 (9.8)
18 (7.6)

63 (8.5)
47 (6.4)

 Gombato
 Ukunda
Person currently living with
 Living alone
 Living with others
Current relationship status

 Married
Parity
 None
 One child
 2+ children
First birth age
 Never given birth
 ≤19 years (adolescents)
 ≥20 years (young women)

the course of the 7-week intervention period (intervention arm—49 (19%); contact arm—42 (17%); control
arm—25 (11%)). Among participants in the intervention
arm, 206 (81%) completed both the baseline and the
endline assessments (making them eligible for CC analysis) while 103 (40%) were eligible for PP analysis. Among
the contact group, 207 (83%) received the push messages
and were included in both the CC and PP analysis. In the
control group, 211 (89.4%) completed both the baseline
and the endline assessments. Baseline characteristics for
the study sample are shown in table 1. Across all arms,
53% of the participants were male, 48% had a secondary

education or higher, 65% were from Ukunda sublocation,
91% lived with others and 85% did not have children.
There were no significant baseline differences between
the intervention, contact and control groups.
Concerning attrition bias, the analysis revealed that
participants who dropped out in each arm were similar
to each other (online supplemental table 1). However,
there was a significant association between dropping out
of the study and the number of children the participant
had at the time of the study in the control and the contact
groups’ participants, online supplemental table 1. The
analysis assessing attrition bias also revealed that there
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Table 1 Baseline characteristics of the participants, by study arm (N=740)
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0.5181

 P value

Numbers in bold are for variables analysed under subject specific analysis
ANOVA, analysis of variance.

n*—Those who believed the myth (had wrong answer).

0.66

 ANOVA test F statistics

 Test of diff. in the mean of the
Control (n=211)
absolute change in myths believed

(−1.54 to –0.68)

 Percentage absolute change in
myths believed

Intervention (n=206)

−22.2

(−1.59 to –0.67)

−21.9

 CI of the diff.

5.01

108 (52.4%)

46 (22.3%)

101 (49%)

92 (44.7%)

83 (40.3%)

102 (49.5%)

112 (54.4%)

120 (58.3%)

125 (60.7%)

144 (69.9%)

3.90

84 (40.8%)

32 (15.5%)

69 (33.5%)

53 (25.7%)

57 (27.7%)

73 (35.4%)

90 (43.7%)

105 (51%)

106 (51.5%)

135 (65.5%)

*Endline

Intervention (n=206)
*Baseline

−1.11

−8.1%

−8.6%

−5.2%

−13.8%

−17.1%

−12.3%

−13.8%

−14.2%

−10%

−10.4%

Diff.

−1.13

4.04

92 (43.6%)

41 (19.4%)

81 (38.4%)

69 (32.7%)

65 (30.8%)

82 (38.9%)

88 (41.7%)

103 (48.8%)

114 (54%)

117 (55.5%)

*Endline

 Average absolute change in myths
believed

 Average # myths believed, per
participant (SE)

5.17

109 (51.7%)

 Women who use family planning/
birth-spacing may become
promiscuous

Subject specific analysis

59 (28%)

101 (47.9%)

 Contraceptives reduce women’s
sexual urges

 Birth control should be a female
concern

108 (51.2%)

 Use of a contraceptive injection
can make a woman permanently
infertile

92 (43.6%)

117 (55.5%)

 Contraceptives can cause cancer

 After a woman uses contraceptive
methods, it is difficult to get
pregnant

133 (63%)

 People who use contraceptives
end up with health problems

98 (46.5%)

135 (64%)

 Contraceptives can harm a
woman’s womb

 Contraceptives can give you
deformed babies

139 (65.9%)

 Hormonal contraceptives are
fattening

Population based analysis

*Baseline

Control (n=211)

Intervention effects for dichotomous outcomes—complete-case analysis

−11.6%

−6.8%

−15.5%

−19%

−12.6%

−14.1%

−10.7%

−7.3%

−9.2%

−4.4%

Diff.

Contact (n=207)

Contact (n=207)

−25.9

(−1.91 to –0.98)

−1.44

5.57

111 (53.6%)

59 (28.5%)

102 (49.3%)

106 (51.2%)

107 (51.7%)

123 (59.4%)

123 (59.4%)

135 (65.2%)

144 (69.6%)

142 (68.6%)

*Baseline

4.12

89 (43%)

35 (16.9%)

80 (38.7%)

71 (34.3%)

76 (36.7%)

77 (37.2%)

86 (41.6%)

100 (48.3%)

112 (54.1%)

127 (61.4%)

*Endline

−10.6%

−11.6%

−10.6%

−16.9%

−15%

−22.2%

−17.8%

−16.9%

−15.5%

−7.2%

Diff.
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Table 2
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was no significant difference in the sociodemographics
between the participants who were lost to follow-up and
those who finished the 7 weeks of the intervention and
took the endline survey, online supplemental table 2.
The results of the CC analysis examining the myths
and misconceptions believed are displayed in table 2.
The myths are ordered by those which were believed
by the most number of participants, across groups, with
the most salient myth at the top. The results show that at
baseline, study participants in all arms believed around
half of the myths related to contraception on average. At
the end of the 7-week intervention period, the average
number of myths and misconceptions believed per participant had significantly decreased for all the three groups
(p<0.0001). The average absolute decrease in the myths
believed was 11.1% among the intervention group (mean
−11.1%; 95% CI −17.1% to −5.2%); 14.4% among the
contact group (mean −14.4%; 95% CI −20.5% to −8.4%)
and 11.3% among the control group (mean −11.3%; 95%
CI −17.4% to −5.2%). From the normality test shown in
figure 2, the absolute change in all the three groups were
normally distributed. The ANOVA test of equality-
of-
populations means showed that there was no significant
difference in the group medians (p=0.5181).

DISCUSSION
Our findings suggest that provision of SRH content via
SMS is potentially useful in dealing with contraception-
related myths and misconceptions among youth. Across
arms, the study demonstrated between a 11% and 14%
reduction in the average number of myths/misconception statements believed over the study period. However,
we did not observe a significant difference in the magnitude of reduction between the arms. Therefore, despite
the significant decrease in myths-
believed that we
observed between baseline and endline, we are unable to
conclusively state that the ARMADILLO intervention was
better than SMS ‘contact’ or no intervention at all.
One possible reason for not seeing a significant effect
of the ARMADILLO intervention versus no intervention
is that correcting false information is difficult. Studies
aimed at correcting misinformation about vaccines, for

Table 3 Difference in difference analysis
Outcome

Percentage point differences (95% CI)

Contraception myths and misconceptions index score (endline – baseline assessment)
 Arm 1: Intervention (Mean∆, 95% CI)
−11.1% (−17.1% to −5.2%)

P value
<0.001

 Arm 2: Contact (Mean∆, 95% CI)

−14.4% (−20.5% to −8.4%)

<0.001

 Arm 3: Control (Mean∆, 95% CI)

−11.3% (−17.4% to −5.2%)

<0.001

 Mean (∆ Intervention) − Mean (∆ Control)

0.2% (−8.3% to 8.7%)

0.961

 Mean (∆ Contact) − Mean (∆ Control)
 Mean (∆ Intervention) − Mean (∆ Contact)

−3.1% (−11.7% to 5.4%)
3.3% (−5.1% to 11.8%)

0.475
0.440

∆ refers to the subject-specific change in the outcome from baseline to endline. 95% CI refers to the 95% CI. A generalised linear model
using a normal distribution and identity link was used to compare scores.
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Figure 2 Checking the normality of the absolute changes in
the myths believed.

As presented in the DID analysis in table 3, there was
no statistically significant differences between the baseline to endline decrease observed across the three arms
(p>0.017-Bonferroni corrected significance level).
Effective sample size used for the analysis was 206 participants for the intervention group; 207 participants for the
contact group and 211 participants for the control group.
Sensitivity analysis including only participants who met
PP inclusion criteria did not alter the findings from CC
analysis. As the results of the CC analysis, and PP analysis
did not differ with respect to statistical significance within
groups or between groups, only those for the CC analysis
are reported (PP analysis is attached as online supplemental table 3).
Finally, table 4 shows estimates of a possible source
of contamination between study arms. Of the 23% of
the participants in the intervention group who shared
the messages with others, 13%, 5% and 4% shared the
messages with friends, partners and multiple contacts,
respectively. Among the 27% contact group participants
who shared the messages with others, 15%, 8%, 1% and
3% shared the messages with friends, partners, siblings
and multiple contacts, respectively.

Open access

Shared the messages with:
Shared the messages

Siblings

Friends

Partner

Parents

Multiple contacts

Intervention
(N=206)

n
%

47
22.8

0
0.0

26
12.6

10
4.9

2
1.0

9
4.4

Contact
(N=207)

n

55

2

30

16

0

7

%

26.6

1.0

14.5

Total
(N=413)

n
%

102
24.7

2
0.5%

56
13.6%

7.7
26
6.3%

0.0
2
0.5%

3.4
16
3.9%

example, have shown that even when attempts to correct
invalid information do not entrench the original misinformation, they can frequently fail because people cannot
successfully update their memories, and still fall back on
information they know is not correct.33–36 A 7-week digital
health intervention, dedicated to SRH broadly, may not
have been enough to dispel deeply entrenched concerns
about contraception. Myths and misconceptions around
contraception are also particularly tricky given that
misconception about contraception generally (eg, that
contraception use can lead to infertility) may be partially
rooted in individual experiences of real side effects (eg,
the possible delay of a return to fertility following use of
injectable contraception).12
Alternatively, we may have seen no difference between
the arms because the intervention was truly not better
than SMS-
prompted self-
learning and/or no intervention at all. Several other RCTs that have attempted to tie
adolescent-targeted digital health interventions to SRH
knowledge, acceptability or behavioural outcomes have
resulted in similarly inconclusive findings,26 37–40 indicating that digital interventions on their own may not
be enough to encourage behavioural change. However,
while the above reasons would explain the lack of difference between arms, they do not explain why participants
in all arms believed significantly fewer myths at endline
than they did at baseline.
Here, contamination between arms may be to blame.
RCT of digital health client communication interventions
are difficult, especially when the intervention content can
be easily shared between neighbours and across communities. To the best of our knowledge, there were no other
health campaigns or interventions aimed at dispelling the
myths and misconceptions in the area during the study
period. However, about a quarter of the intervention and
contact arm participants reported sharing information
with study participants and other members of the community. Any effect of participants sharing information was
amplified by our participants being randomised at the
individual level. This resulted in participants in different
arms living in close proximity, often in neighbouring
households. ARMADILLO intervention arm participants
may therefore have received the messages and shared
them with their friends/neighbours, some of whom were
ARMADILLO contact and control arm participants.

Addressing/dispelling myths and misconceptions
among youth is particularly important for future contraception use. By nature of originating in social networks as
well as their likelihood to ‘stick’ indefinitely, myths and
misconceptions among youth should be dispelled early to
prevent their becoming engrained.6 41 Indeed, our study
believed
found that two of the three most commonly-
myths and misconceptions among youth age 18–24 years
(people who use contraceptives end up with health problems, and contraceptives can harm a woman’s womb)
were also the top myths for youth and adult women aged
15–49 years in Kenya, Nigeria and Senegal.9
Other studies have reported successfully addressing
myths and misconceptions with dedicated community
and communication interventions,42 involving a variety of
opinion leaders and channels.9 42 Following a 4-year intervention using radio, religious leaders and community
health volunteers, for example, Kenya’s Tupange study
reported a 15% decrease in the number of women who
believed myths and misconceptions statements between
baseline and endline.42
Digital interventions are an additional channel which
can be included in this mix. There is a wealth of opportunity to engage with young people en masse not only
through SMS and voice channels, but also by widely used
messaging and social media platforms like WhatsApp,
Facebook and Facebook Messenger, the latter of which
don’t have the bulk telecom-related costs of SMS and
voice interventions. The popularity of the ARMADILLO
interventions among its users—one silver lining of the
contamination between arms—indicate that such interventions can be considered as one tool in a multipronged
approach targeting young people with correct SRH information.25 43–45 However, evidence continues to be needed
on adolescent-targeted client communication interventions in general.
This study is not without limitations. The lack of differences between the intervention and the other arms
could very well be due to our adoption of individually
randomised rather than cluster randomised study design.
A cluster design was considered; however, the accessibility
and make-up of the study area did not allow for homogeneous clusters to be created (Ukunda, eg, is unique in
Kwale County for its population density). While unfortunate for the results of the trial, it demonstrates that the
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Table 4 Study contamination
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